Acute myeloid leukemia and Langerhans' cell histiocytosis: Multiple theories for an unusual presentation

Leukemia Research

Volumn 34, Issue 3, 2010, Pages 406-408

  Ghosn, Marwan G ^a   Haddad, Amin C ^a   Nassar, Michel N ^a   Abadjian, Gerard A ^a   Karak, Fady R El ^a   Aftimos, Philippe G ^a  

^a SAINT JOSEPH UNIVERSITY   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE;

ACUTE GRANULOCYTIC LEUKEMIA; AGED; ANAMNESIS; ARTICLE; BLAST CELL; BONE MARROW BIOPSY; CANCER CHEMOTHERAPY; CASE REPORT; CELL INFILTRATION; CERVICAL LYMPHADENOPATHY; CLINICAL FEATURE; HISTIOCYTOSIS X; HUMAN; HUMAN CELL; HUMAN TISSUE; INGUINAL LYMPH NODE; LANGERHANS CELL; LYMPH NODE BIOPSY; MALE; PRIORITY JOURNAL;

AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CHROMOSOMES, HUMAN, PAIR 8; CYTARABINE; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; NEOPLASMS, SECOND PRIMARY; TRISOMY;

EID: 77649187758     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2009.07.025     Document Type: Article

References (24)

1. Cline M.J. Histiocytes and histiocytosis. Blood 1994, 84:2840-2853.
2. Austyn J.M. Lymphoid dendritic cells. Immunology 1987, 62:161-170.
3. Tilly H., Castaigne S., Bordessoule D., et al. Low-dose cytarabine versus intensive chemotherapy in the treatment of acute nonlymphocytic leukemia in the elderly. J Clin Oncol 1990, 8:272-279.
4. Coppes-Zantinga A., Egeler R.M. The Langerhans cell histiocytosis X files revealed. Br J Haematol 2002, 116:3-9.
5. Beverley P.C., Egeler R.M., Arceci R.J., Pritchard J. The Nikolas Symposia and histiocytosis. Nat Rev Cancer 2005, 5:488-494.
6. Favara B.E. Langerhans' cell histiocytosis pathobiology and pathogenesis. Semin Oncol 1991, 18:3-7.
7. Yu R.C., Morris J.F., Pritchard J., Chu T.C. Defective alloantigen-presenting capacity of 'Langerhans cell histiocytosis cells'. Arch Dis Child 1992, 67:1370-1372.
8. Geissmann F., Lepelletier Y., Fraitag S., et al. Differentiation of Langerhans cells in Langerhans cell histiocytosis. Blood 2001, 97:1241-1248.
9. McClain K., Jin H., Gresik V., Favara B. Langerhans cell histiocytosis: lack of a viral etiology. Am J Hematol 1994, 47:16-20.
10. Egeler R., Favara B.E., van Meurs M., Laman J.D., Claassen E. Differential in situ cytokine profiles of Langerhans-like cells and T cells in Langerhans cell histiocytosis: abundant expression of cytokines relevant to disease and treatment. Blood 1999, 94:4195-4201.
11. Egeler R.M., Neglia J.P., Puccetti D.M., Brennan C.A., Nesbit M.E. Association of Langerhans cell histiocytosis with malignant neoplasms. Cancer 1993, 71:865-873.
12. Egeler R.M., Neglia J.P., Arico M., et al. The relation of Langerhans cell histiocytosis to acute leukemia, lymphomas, and other solid tumors. The LCH-Malignancy Study Group of the Histiocyte Society. Hematol Oncol Clin North Am 1998, 12:369-378.
13. Horibe K., Matsushita T., Shin-Ichiro N., et al. Acute promyelocytic leukemia with t(15;17) abnormality after chemotherapy containing etoposide for Langerhans cell histiocytosis. Cancer 1993, 72:3723-3726.
14. Haupt R., Fears T.R., Rosso P., et al. Increased risk of secondary leukemia after single-agent treatment with etoposide for Langerhans cell histiocytosis. Pediatr Hematol Oncol 1994, 11:499-507.
15. Haupt R., Fearf T.R., Heise A., et al. Risk of secondary leukemia after treatment with etoposide (VP-16) for Langerhans cell histiocytosis in Italian and Austrian-German populations. Int J Cancer 1997, 71:9-13.
16. Fontana J., Koss W., McDaniel D., Jenkins J., Welton W. Histiocytosis X and acute monocytic leukaemia. Biologic illustration of the monocyte phagocytic system. Am J Med 1987, 82:137-142.
17. Segal G.H., Mesa M.V., Fishleder A.J., et al. Precursor Langerhans cell histiocytosis. An unusual histiocytic proliferation in a patient with persistent non-Hodgkin lymphoma and terminal acute monocytic leukaemia. Cancer 1992, 70:547-553.
18. Misery L., Guyotat D., Cambazard F. Association of Langerhans-cell histiocytosis and acute monocytic leukemia. Ann Dermatol Venereol 1998, 125:732-733.
19. Hermanns-Lê T., Arrese J.E., Piérard G.E. Langerhans histiocytosis and acute monoblastic leukemia type LMA4. Ann Dermatol Venereol 1998, 125:124-126.
20. Favara B.E., Feller A.C., Pauli M., et al. Contemporary classification of histiocytic disorders. Med Pediatr Oncol 1997, 29:157-166.
21. Okubo T., Asou N., Suzushima H., et al. Reactive histiocytosis during initial remission induction therapy for acute myeloblastic leukemia. Rinsho Ketsueki 1992, 33:1824-1828.
22. Meyers C.A., Albitar M., Estey E. Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome. Cancer 2005, 104:788-793.
23. Byrd J.C., Edenfield W.J., Shields D.J., Dawson N.A. Extramedullary myeloid cell tumors in acute non-lymphocytic leukemia: a clinical review. J Clin Oncol 1995, 13:1800-1816.
24. Rodig S., Payne E., Degar B., et al. Aggressive Langerhans cell histiocytosis following T-ALL: clonally related neoplasms with persistent expression of constitutively active NOTCH1. Am J Hematol 2008, 83:116-121.